Donda A - Search Results

1

Direct presentation of a melanocyte-associated antigen in peripheral lymph nodes induces cytotoxic CD8+ T cells.

Schuler P, Contassot E, Irla M, Hugues S, Preynat-Seauve O, Beermann F, Donda A, French LE, Huard B. Schuler P, et al. Among authors: donda a. Cancer Res. 2008 Oct 15;68(20):8410-8. doi: 10.1158/0008-5472.CAN-08-0809. Cancer Res. 2008. PMID: 18922914 Free article.

2

Adjuvants that improve the ratio of antigen-specific effector to regulatory T cells enhance tumor immunity.

Perret R, Sierro SR, Botelho NK, Corgnac S, Donda A, Romero P. Perret R, et al. Among authors: donda a. Cancer Res. 2013 Nov 15;73(22):6597-608. doi: 10.1158/0008-5472.CAN-13-0875. Epub 2013 Sep 18. Cancer Res. 2013. PMID: 24048821

3

Serial Stimulation of Invariant Natural Killer T Cells with Covalently Stabilized Bispecific T-cell Engagers Generates Antitumor Immunity While Avoiding Anergy.

Kharkwal SS, Johndrow CT, Veerapen N, Kharkwal H, Saavedra-Avila NA, Carreño LJ, Rothberg S, Zhang J, Garforth SJ, Jervis PJ, Zhang L, Donda A, Besra AK, Cox LR, Almo SC, Howell A, Evans EE, Zauderer M, Besra GS, Porcelli SA. Kharkwal SS, et al. Among authors: donda a. Cancer Res. 2021 Apr 1;81(7):1788-1801. doi: 10.1158/0008-5472.CAN-20-2219. Epub 2021 Jan 22. Cancer Res. 2021. PMID: 33483371 Free PMC article.

4

Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.

Cesson V, Stirnemann K, Robert B, Luescher I, Filleron T, Corradin G, Mach JP, Donda A. Cesson V, et al. Among authors: donda a. Clin Cancer Res. 2006 Dec 15;12(24):7422-30. doi: 10.1158/1078-0432.CCR-06-1862. Clin Cancer Res. 2006. PMID: 17189415

5

In vivo targeting of an anti-tumor antibody coupled to antigenic MHC class I complexes induces specific growth inhibition and regression of established syngeneic tumor grafts.

Donda A, Cesson V, Mach JP, Corradin G, Primus FJ, Robert B. Donda A, et al. Cancer Immun. 2003 Aug 14;3:11. Cancer Immun. 2003. PMID: 12916958

6

MicroRNA-155 Expression Is Enhanced by T-cell Receptor Stimulation Strength and Correlates with Improved Tumor Control in Melanoma.

Martinez-Usatorre A, Sempere LF, Carmona SJ, Carretero-Iglesia L, Monnot G, Speiser DE, Rufer N, Donda A, Zehn D, Jandus C, Romero P. Martinez-Usatorre A, et al. Among authors: donda a. Cancer Immunol Res. 2019 Jun;7(6):1013-1024. doi: 10.1158/2326-6066.CIR-18-0504. Epub 2019 May 1. Cancer Immunol Res. 2019. PMID: 31043416

7

CART cells are prone to Fas- and DR5-mediated cell death.

Tschumi BO, Dumauthioz N, Marti B, Zhang L, Lanitis E, Irving M, Schneider P, Mach JP, Coukos G, Romero P, Donda A. Tschumi BO, et al. Among authors: donda a. J Immunother Cancer. 2018 Jul 13;6(1):71. doi: 10.1186/s40425-018-0385-z. J Immunother Cancer. 2018. PMID: 30005714 Free PMC article.

8

Presentation of the same glycolipid by different CD1 molecules.

Shamshiev A, Gober HJ, Donda A, Mazorra Z, Mori L, De Libero G. Shamshiev A, et al. Among authors: donda a. J Exp Med. 2002 Apr 15;195(8):1013-21. doi: 10.1084/jem.20011963. J Exp Med. 2002. PMID: 11956292 Free PMC article.

9

Thymocytes control the CD4 gene differently from mature T lymphocytes.

Uematsu Y, Donda A, De Libero G. Uematsu Y, et al. Among authors: donda a. Int Immunol. 1997 Jan;9(1):179-87. doi: 10.1093/intimm/9.1.179. Int Immunol. 1997. PMID: 9043959

10

Self glycolipids as T-cell autoantigens.

Shamshiev A, Donda A, Carena I, Mori L, Kappos L, De Libero G. Shamshiev A, et al. Among authors: donda a. Eur J Immunol. 1999 May;29(5):1667-75. doi: 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U. Eur J Immunol. 1999. PMID: 10359121 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page